​Biomedical Research at Steno Diabetes Center Copenhagen is translational. The aim is to apply knowledge and findings from research in the clinic to improve outcomes for patients with type 1 and type 2 diabetes.

Research is organised in these areas:

  • Complication research: Understanding the prevention and treatment of diabetic micro- and macrovascular complications of diabetes
  • Clinical epidemiology: Developing preventive strategies for persons with reduced glucose metabolism and early treatment strategies for persons with type 2 diabetes
  • Systems Medicine: System-level understanding of metabolism and translation of this knowledge into novel solutions to benefit human health

Strategic goals include

  • to identify therapeutic goals and develop strategies for the prevention and early detection of diabetes and other phenotype of the metabolic syndrome
  • to identify therapeutic goals for the prevention and treatment of late diabetic complications through studies of genetic and non-genetic mechanisms leading to micro- and macrovascular complications
  • to optimise new and existing treatments and intervention strategies through clinical trials and pharmacogenetic studies in order to improve the prognosis and quality of life of persons with diabetes and other phenotypes of the metabolic syndrome
  • to ensure the transferring of scientific achievements to clinically applicable treatment strategies and, in turn, to ensure that new research-based knowledge is implemented in clinical practice


The research groups have formalised partnerships and affiliations with leading centers in Denmark and abroad including


The Steno Research Center builds on a history of more than 80 years where clinical care and diabetes research has gone hand in hand to the benefit of patients. Significant landmark studies have been published over the years and the research groups remain highly productive.

Research is headed by Birgitte Brock. 

Responsible editor